Evidence map›Paper›PMID 37040373›Full record

ArticlePloS one2023

Enabling low-cost and robust essentiality studies with high-throughput transposon mutagenesis (HTTM).

Antoine Champie, Amélie De Grandmaison, Simon Jeanneau, Frédéric Grenier, Pierre-Étienne Jacques, Sébastien Rodrigue

Abstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Antoine ChampieDépartement de biologie, Université de Sherbrooke, Sherbrooke, Québec, Canada.
Amélie De GrandmaisonDépartement de biologie, Université de Sherbrooke, Sherbrooke, Québec, Canada.
Simon JeanneauDépartement de biologie, Université de Sherbrooke, Sherbrooke, Québec, Canada.
Frédéric GrenierDépartement de biologie, Université de Sherbrooke, Sherbrooke, Québec, Canada.
Pierre-Étienne JacquesDépartement de biologie, Université de Sherbrooke, Sherbrooke, Québec, Canada.
Sébastien RodrigueDépartement de biologie, Université de Sherbrooke, Sherbrooke, Québec, Canada.ORCID 0000-0002-5366-7234

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transposon-insertion sequencing (TIS) methods couple high density transposon mutagenesis with next-generation sequencing and are commonly used to identify essential or important genes in bacteria. However, this approach can be work-intensive and sometimes expensive depending on the selected protocol. The difficulty to process a high number of samples in parallel using standard TIS protocols often restricts the number of replicates that can be performed and limits the deployment of this technique to large-scale projects studying gene essentiality in various strains or growth conditions. Here, we report the development of a robust and inexpensive High-Throughput Transposon Mutagenesis (HTTM) protocol and validate the method using Escherichia coli strain BW25113, the parental strain of the KEIO collection. HTTM reliably provides high insertion densities with an average of one transposon every ≤20bp along with impressive reproducibility (Spearman correlation coefficients >0.94). A detailed protocol is available at protocol.io and a graphical version is also included with this article.

Indexed as

DNA Transposable ElementsHigh-Throughput Nucleotide SequencingEscherichia coliMutagenesisReproducibility of ResultsResearchDNA Transposable Elements

Identifiers

PMID37040373
PMCPMC10089323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.